1

Mini-antibodies Reactivate tumor suppressor p53: A New Approach for Cancer Management

News Discuss 
A critical advance in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This essential malignant protector protein is frequently lost in various forms of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story